Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
about
Efficiency of diagnostic methods for correlation between prevalence of enteric protozoan parasites and HIV/AIDS status--an experience of a tertiary care hospital in East Delhi.Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral TherapyIntestinal parasitic infections in HIV/AIDS patients presenting with diarrhoea in Jakarta, Indonesia.Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count.Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia.The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.HIV associated hypocalcaemia among diarrheic patients in northwest Ethiopia: a cross sectional study.Sources of emotional distress associated with diarrhea among late middle-age and older HIV-infected adults.Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial.HIV protease inhibitors in gut barrier dysfunction and liver injury.Parasitic infections in HIV infected individuals: diagnostic & therapeutic challengesCrofelemer: a review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy.Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy.A population-based study of the extent of colorectal cancer screening in men with HIVHealth-related quality of life assessment after antiretroviral therapy: a review of the literature.Intestinal Parasitosis in Relation to Anti-Retroviral Therapy, CD4(+) T-cell Count and Diarrhea in HIV PatientsClinical and Microbiological Profile of HIV/AIDS Cases with Diarrhea in North IndiaCrofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDSOral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy.Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire.Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.Burden and risk factors for gastrointestinal symptom distress in HIV patients in the modern antiretroviral era.[Enteropathogens relating to diarrhea in HIV patients on antiretroviral therapy].Performance evaluation of point-of-care test for detection of Cryptosporidium stool antigen in children and HIV infected adults.Lopinavir/ritonavir dosage form affects quality of life during monotherapy in HIV-positive adults.Global impact of antiretroviral therapy-associated diarrhea.Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea.The association of HIV/AIDS treatment side effects with health status, work productivity, and resource use.The relationship between gastrointestinal symptom attribution, bothersomeness, and antiretroviral adherence among adults with HIV.HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia.Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey
P2860
Q30407687-17583D4E-1B8B-48BF-85FB-C5E6C1CC48D6Q30609066-854CE82E-67DB-44B2-AE30-0B94FFDF54ADQ33423370-12F0B1E7-D610-4023-8F5A-AA5FCC18236BQ33504912-25DB87C3-034C-4A59-AA09-1181EBC53C58Q33548540-902B5C4C-FA28-4807-9537-515846B160F1Q33595797-5ACB2B04-16C3-4BFC-B791-BC006FA87373Q33907278-CC90842A-1710-4C63-842B-378FD76EF15CQ34106384-9A7F15F4-3711-4AE6-AF15-9F78346B052DQ34343642-34F515CD-BF3E-4C02-93D1-C9902F2626C4Q34617496-23B6DC60-BA4A-4234-9302-9A2CC193D58AQ34635675-1A30ECCD-AD64-4DE1-983A-3AC151D7B6A6Q34653691-7FB1937B-AFF5-4AD4-9AC7-CE7D3F7B002AQ34668617-D464D7A6-07D1-4A7F-BECF-17577ADEAA85Q35052601-B301AE75-8F96-49B4-8531-2AAB7BED7544Q35664740-5DBA2A1E-42E1-49B0-8CA0-9AA030CB1F82Q36497371-25EA9B32-1BA2-4469-BDB3-3142F68752D7Q36528442-92D504D2-FBE5-401E-AF0B-A9623751655DQ37042269-C05737C8-5289-4F37-A1A9-8967C507C492Q37124381-B07D1FE6-6439-404D-9A8E-D27AF88F89D2Q37162353-0AB81AF7-1ACB-4462-9AED-11D403B96487Q38144148-35120FFF-1EDC-46DC-AE8D-B25DA8E9AF7EQ38620255-D398F7C9-4FB0-4562-BB2A-3729D161EDA2Q39563792-48F562B9-286F-48E2-8404-29ED5B2918B9Q41436459-E232BA35-8340-4DDF-BFD8-3680582D3D36Q41855629-2DD8DBED-3D28-485A-80B3-B174CED618B4Q42907386-45E6074F-1F76-4AE5-98C2-94378E1E6B03Q43109126-997861E9-A02E-433C-B3B7-D21610BD4331Q46439906-E7C74413-E5AD-4416-96EC-C9B0373F1A2FQ48261239-A80B10C5-F688-450A-AE05-677EBF7317B7Q50131597-F4C7E6E2-900B-4B11-9721-289172387DCEQ51735536-FAB81F82-4491-4893-A020-ABC67DF91011Q58800747-88F82438-2275-423D-BE30-AA205A22E632
P2860
Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prevalence and impact of diarr ...... active antiretroviral therapy.
@ast
Prevalence and impact of diarr ...... active antiretroviral therapy.
@en
Prevalence and impact of diarr ...... active antiretroviral therapy.
@nl
type
label
Prevalence and impact of diarr ...... active antiretroviral therapy.
@ast
Prevalence and impact of diarr ...... active antiretroviral therapy.
@en
Prevalence and impact of diarr ...... active antiretroviral therapy.
@nl
prefLabel
Prevalence and impact of diarr ...... active antiretroviral therapy.
@ast
Prevalence and impact of diarr ...... active antiretroviral therapy.
@en
Prevalence and impact of diarr ...... active antiretroviral therapy.
@nl
P2093
P921
P1476
Prevalence and impact of diarr ...... active antiretroviral therapy.
@en
P2093
Danise Schiliro
Edmund J Bini
Jennifer Leong
Khushbu Chandarana
Sabena Ramsetty
Uzma Siddiqui
P304
P356
10.1097/01.MCG.0000225694.46874.FC
P577
2007-05-01T00:00:00Z